The private company linked to the Department of Budget and Management’s much-criticized procurement deals made a P393 million profit from April to June 2020, according to Senate Minority Leader Franklin Drilon.
"Pharmally’s profit came from sales to DBM from April to June 2020. They (DBM) could’ve gone straight to the manufacturer, why did they have to go through Pharmally?," Drilon asked.
Drilon renewed his call to Pharmally officials to appear before the Senate’s probe into theP10 billion supply deals that the firm got from DBM.
The minority leader challenged the Pharmally executives to appear before the probe if they are not hiding anything because “I have many questions.”
Meanwhile, the opposition senator also asked whether Pharmally was able to pay taxes after the government awarded multi-billion peso contracts to the firm.
Malacañang, for its part, earlier said it did not need to check the profile of Pharmally, which allegedly had links with former presidential adviser Michael Yang.
